Immune checkpoint inhibitors and diabetes mellitus

Abstract:

Diabetes mellitus caused by immune checkpoint inhibitors is a rare type of immune-related adverse events in endocrinology. However, this type of diabetes often begins with diabetic ketoacidosis, which is more dangerous. This article reviews the literatures on immune checkpoint inhibitors-induced diabetes mellitus and its clinical manifestations and diagnosis and treatment strategies.